Elif A Oral

8.4k total citations · 3 hit papers
105 papers, 5.4k citations indexed

About

Elif A Oral is a scholar working on Molecular Biology, Genetics and Physiology. According to data from OpenAlex, Elif A Oral has authored 105 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Biology, 31 papers in Genetics and 21 papers in Physiology. Recurrent topics in Elif A Oral's work include Nuclear Structure and Function (59 papers), Diabetes and associated disorders (28 papers) and RNA Research and Splicing (18 papers). Elif A Oral is often cited by papers focused on Nuclear Structure and Function (59 papers), Diabetes and associated disorders (28 papers) and RNA Research and Splicing (18 papers). Elif A Oral collaborates with scholars based in United States, Türkiye and Australia. Elif A Oral's co-authors include Phillip Görden, Alex M. DePaoli, Simeon I. Taylor, Abhimanyu Garg, Elaine Cochran, Vinaya Simha, Ahalya Premkumar, Gary W. Cline, Charlotte E. Ariyan and Kitt Falk Petersen and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Investigation.

In The Last Decade

Elif A Oral

95 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Leptin-Replacement Therapy for Lipodystrophy

2002 913 citations Elif A Oral, Alex M. DePaoli et al. profile →
Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy

2002 581 citations Kitt Falk Petersen, Elif A Oral et al. Journal of Clinical Investigation profile →
Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy

2002 503 citations Kitt Falk Petersen, Elif A Oral et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elif A Oral United States	33	2.6k	1.9k	1.6k	1.2k	1.1k	105	5.4k
Haruhiko Osawa Japan	33	1.1k 0.4×	1.1k 0.6×	1.2k 0.7×	473 0.4×	825 0.8×	146	3.9k
Susan Kralisch Germany	35	1.3k 0.5×	2.4k 1.3×	2.6k 1.7×	789 0.7×	227 0.2×	73	5.0k
Katherine Cianflone Canada	35	946 0.4×	1.5k 0.8×	1.2k 0.7×	661 0.5×	274 0.3×	91	3.9k
Ffolliott M. Fisher United States	22	3.1k 1.2×	2.0k 1.0×	1.9k 1.2×	506 0.4×	286 0.3×	24	5.3k
Ulrike Lössner Germany	37	1.1k 0.4×	1.4k 0.7×	1.7k 1.0×	449 0.4×	196 0.2×	81	3.7k
Louise Nordfors Sweden	29	633 0.2×	1.1k 0.6×	1.1k 0.7×	827 0.7×	288 0.3×	67	3.6k
Z Lacinová Czechia	30	900 0.3×	990 0.5×	734 0.5×	427 0.4×	192 0.2×	109	3.0k
Sayuko Kobes United States	31	1.2k 0.4×	678 0.4×	618 0.4×	289 0.2×	1.3k 1.2×	86	3.3k
Johan Permert Sweden	37	1.6k 0.6×	1.2k 0.6×	621 0.4×	314 0.3×	380 0.3×	140	4.8k
Gabriele E. Sonnenberg United States	26	473 0.2×	1.1k 0.6×	911 0.6×	555 0.5×	433 0.4×	60	2.8k

Countries citing papers authored by Elif A Oral

Since Specialization

Citations

This map shows the geographic impact of Elif A Oral's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elif A Oral with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elif A Oral more than expected).

Fields of papers citing papers by Elif A Oral

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elif A Oral. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elif A Oral. The network helps show where Elif A Oral may publish in the future.

Co-authorship network of co-authors of Elif A Oral

This figure shows the co-authorship network connecting the top 25 collaborators of Elif A Oral. A scholar is included among the top collaborators of Elif A Oral based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elif A Oral. Elif A Oral is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Foss‐Freitas, Maria Cristina, et al.. (2025). Advances of pharmacological therapies in lipodystrophy syndromes: current evidence and future directions. Expert Review of Endocrinology & Metabolism. 20(6). 565–592.

2.

Ames, Elizabeth G., Shane C. Quinonez, Anthony Scott, et al.. (2025). Genetics Evaluation Outcomes From an Academic Multidisciplinary Atypical Diabetes Program. Journal of the Endocrine Society. 9(8). bvaf091–bvaf091.

3.

Şimşir, İlgın Yıldırım, Caterina Pelosini, Giovanni Ceccarini, et al.. (2025). Potential Impact of Parental Origin of Inheritance on the Clinical Presentation of Familial Partial Lipodystrophy Type 2 Syndrome. Clinical Endocrinology. 103(4). 504–512.

4.

Foss‐Freitas, Maria Cristina, Brigid Gregg, Rochelle N. Naylor, et al.. (2025). GLP-1 RA and dual GIP/GLP-1 RA treatment in MODY: a descriptive case series. BMJ Open Diabetes Research & Care. 13(2). e004885–e004885.

5.

Bajaj, Archna, Elif A Oral, Alan S. Brown, et al.. (2025). Clinical considerations for the treatment of patients with familial chylomicronemia syndrome using a hepatic-targeted APOC3 antisense oligonucleotide. American Journal of Preventive Cardiology. 24. 101352–101352.

6.

Özen, Samim, Semra Çeti̇nkaya, Leyla Akın, et al.. (2023). A National Multicenter Study of Leptin and Leptin Receptor Deficiency and Systematic Review. The Journal of Clinical Endocrinology & Metabolism. 108(9). 2371–2388. 7 indexed citations

7.

Luo, Yingying, Raad A. Haddad, Matheos Yosef, et al.. (2023). Impact of diabetes on weight loss outcomes after bariatric surgery: Experience from 5‐year follow‐up of Michigan Bariatric Surgery Cohort. Clinical Endocrinology. 99(3). 285–295. 7 indexed citations

8.

Foss‐Freitas, Maria Cristina, İlgın Yıldırım Şimşir, Korcan Demir, et al.. (2023). Deciphering the Clinical Presentations in LMNA-related Lipodystrophy: Report of 115 Cases and a Systematic Review. The Journal of Clinical Endocrinology & Metabolism. 109(3). e1204–e1224. 10 indexed citations

9.

Akıncı, Barış, André Monteiro da Rocha, Rasimcan Meral, et al.. (2021). Cardiac phenotype in familial partial lipodystrophy. Clinical Endocrinology. 94(6). 1043–1053. 14 indexed citations

10.

Affinati, Alison H., Nazanene H. Esfandiari, Elif A Oral, & Andrew Kraftson. (2019). Bariatric Surgery in the Treatment of Type 2 Diabetes. Current Diabetes Reports. 19(12). 156–156. 70 indexed citations

11.

Esfandiari, Nazanene H., Melvyn Rubenfire, Adam Neidert, et al.. (2019). Diagnosis of acquired generalized lipodystrophy in a single patient with T-cell lymphoma and no exposure to Metreleptin. SHILAP Revista de lepidopterología. 5(1). 4–4. 7 indexed citations

12.

Esfandiari, Nazanene H., Yingying Luo, Angela Subauste, et al.. (2018). Metabolic Parameters, Weight Loss, and Comorbidities 4 Years After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy. Obesity Surgery. 28(11). 3415–3423. 31 indexed citations

13.

Chiquette, Elaine, Elif A Oral, Abhimanyu Garg, David Araújo‐Vilar, & Praveen Dhankhar. (2017). Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges. Diabetes Metabolic Syndrome and Obesity. Volume 10. 375–383. 94 indexed citations

14.

Dhankhar, Praveen, et al.. (2015). Estimating Quality of Life of Patients with Lipodystrophy. Value in Health. 18(3). A292–A292. 3 indexed citations

15.

Reilly, Shannon M., Maryam Ahmadian, Brian F. Zamarron, et al.. (2015). A subcutaneous adipose tissue–liver signalling axis controls hepatic gluconeogenesis. Nature Communications. 6(1). 6047–6047. 71 indexed citations

16.

Fajans, Stefan S., William H. Herman, & Elif A Oral. (2010). Insufficient sensitivity of hemoglobin A1C determination in diagnosis or screening of early diabetic states. Metabolism. 60(1). 86–91. 32 indexed citations

17.

Petersen, Kitt Falk, Elif A Oral, Sylvie Dufour, et al.. (2002). Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. Journal of Clinical Investigation. 109(10). 1345–1350. 44 indexed citations

18.

Petersen, Kitt Falk, Elif A Oral, Sylvie Dufour, et al.. (2002). Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. Journal of Clinical Investigation. 109(10). 1345–1350. 503 indexed citations breakdown →

19.

Oral, Elif A. (2002). Effect of Leptin Replacement on Pituitary Hormone Regulation in Patients with Severe Lipodystrophy. The Journal of Clinical Endocrinology & Metabolism. 87(7). 3110–3117. 25 indexed citations

20.

Erel, C. Tamer, et al.. (2001). Craniopharyngioma and Bardet-Biedl syndrome. A case report.. PubMed. 46(5). 501–3. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact